Thad Allen Huston
Chief Financial Officer · Artiva Biotherapeutics, Inc.
Individual
- 2026
- Mar 10, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thad Allen Huston files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- GC Corp. - $16.50M in ARTV purchases and sales in the last 12 months
- Fred Aslan - $1.96M in ARTV purchases and sales in the last 12 months
- Christopher Horan - $249K in ARTV purchases and sales in the last 12 months
- Jennifer Bush - $230K in ARTV purchases and sales in the last 12 months
- Subhashis Banerjee - $187K in ARTV purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thad Allen Huston?
Thad Allen Huston is a corporate insider, tracked as Chief Financial Officer of Artiva Biotherapeutics, Inc. (ARTV). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Thad Allen Huston last file a Form 4?
The only primary Form 4 on record is dated 10 March 2026.
